AC
Applied Clinical Trials
ACT Brief: China’s Startup Timelines, AI-Drafted Clinical Study Reports, and Bimzelx Psoriatic Arthritis Data
0:00-1:47
In today’s ACT Brief, we examine how China’s trial startup timelines compare with those in the US and Europe, whether AI-drafted clinical study reports speed drug development, and how Bimzelx compared with Skyrizi in psoriatic arthritis.
Publisher
Applied Clinical Trials
Link
audioboom.com/posts/8975115
Published
November 10, 2026
Duration
2 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
AC
Applied Clinical Trials
@appliedclinicaltrials
#chinasstartuptimelines #draftedclinicalstudy #bimzelxpsoriaticarthritis #lifesciences
